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ABSTRACT
This paper describes a novel assay for measuring the relative extent of peptide
binding in a large parallel format, and the use of this assay to explore the effects
of sequence context on the binding of tryptophan (Trp)-containing peptides by
the

synthetic

receptor

comprising

the

noncovalent

complex

between

cucurbit[8]uril and methyl viologen (i.e., Q8•MV). The extent of quenching of
Trp fluorescence upon binding to Q8•MV was used to measure the relative
extent of binding and thus the relative affinities of 104 Trp-containing peptides,
in parallel, using a fluorescence plate reader. This study resulted in the
remarkable observation that the identity of the amino acid residues at positions
adjacent to the Trp binding site has little if any influence on the binding affinity.
This finding suggests that Q8•MV should be effective for the recognition of Trp
residues within a broad range of peptide sequences.
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1. Introduction
Synthetic receptors that can bind to peptides with well-defined affinities and
specificities would have enormous value for biomedical science and technology.
The recognition properties of natural protein receptors may depend on specificity
for a certain type of amino acid residue (e.g., N-recognins, kinases,
endopeptidases) (1-3) or a certain type of peptide sequence or small protein
fragment (e.g., antibodies, cell-surface receptors). In any case, it is important to
understand how the sequence environment (i.e., neighboring residues)
influences binding. Several synthetic receptors have been shown to bind peptides
and proteins (4-17), but in the majority of cases, these receptors are known to
bind to a single type of residue, and the effects of sequence context are
understood to a limited extent. This paper describes the effects of sequence
context on the interactions of tryptophan-containing peptides with the synthetic
receptor, cucurbit[8]uril (Q8), and a method that enables this determination in a
rapid and parallel fashion.
Q8 is a tire-shaped, macrocyclic oligomer of bis(methylene)-bridged
glycoluril, whose hydrophobic inner space and polar rims drive the inclusion of
cationic, organic, small molecules (18,19). Compared to other cucurbit[n]urils, Q8
has been studied extensively for its ability to bind two guests simultaneously in
aqueous solution (20-29). Much of our work with Q8 has focused on the
molecular recognition of peptides (30-36). We have shown that, when bound to
methyl viologen (MV) or tetramethyl benzobis(imidazolium) as the first guest,
Q8 binds to peptides containing tryptophan (Trp) with preference for Trp at the
N-terminal position (Trp-Gly-Gly; Gly = glycine) versus nonterminal (Gly-TrpGly) or C-terminal (Gly-Gly-Trp) positions (Figure 1) (32, 36). Others have used
this approach for peptide separation and protein assays (37-40). We are
interested in the efficacy of peptide recognition across a broad array of sequence
contexts. Specifically, we want to know how residues adjacent to the Trp
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binding site may influence the binding of Q8•MV. For example, can a basic
residue such as lysine or arginine positioned to the N-terminal side of Trp
approximate the N-terminal ammonium group that is known to stabilize the
binding of cucurbit[n]urils to N-terminal aromatic peptides? Do bulky residues
interfere sterically with binding? Small peptides are straightforward to
synthesize and characterize in small numbers. Ideally, however, we would like to
measure and compare the effects of varying the identity of the residues at
positions neighboring the Trp binding site to all possible amino acids, and thus
we need to synthesize and screen a library of peptides.
An interesting characteristic of the Q8•MV•Trp system is its optical sensing
capabilities. We and others have observed that Trp binding is accompanied by
the growth of a new charge-transfer absorbance and the quenching of indole
fluorescence (36, 41). Here we present an assay that uses these supramolecular
and optical properties to compare in parallel the extent of binding of Q8•MV to a
library of 104 Trp-containing peptides by comparing the relative extents of
fluorescence quenching. Remarkably, we observe no significant effect of
sequence context on Trp binding.

2. Results and Discussion
2.1. Design
The peptide library (Figure 2) was designed such that each peptide contained a
tryptophan binding site at either an N-terminal or non-terminal position in order
to account for the expected difference in affinity due to the location of the Trp
residue (42). The C-terminal position was not investigated because it is the
lowest affinity site. The N-terminal Trp-containing peptides were tripeptides of
sequence Trp-Var1-Var2, and the non-terminal Trp-containing peptides were
pentapeptides of sequence Var1-Var2-Trp-Var3-Var4. The variable (Var) positions
were each varied among 18 genetically encoded amino acids (43) while holding
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the other position(s) constant with Ala residues. Ala was chosen as the spacer
because its beta-methyl group is the largest sidechain fragment that represents
the structures of the other amino acids (all except Gly). This design resulted in a
library of 104 peptides (44). The peptide library was synthesized by parallel
solid-phase synthesis on Rink amide resin (see Supporting Information).

2.2. Parallel Peptide-Binding Assay
The peptide-binding assay is based on the built-in optical sensing capability
of the Q8•MV•Trp system, in which the binding of Trp to Q8•MV results in the
quenching of indole fluorescence with a linear correlation between the observed
extent of fluorescence quenching and the fraction of indole-containing
compound bound to Q8•MV (calculated from the known binding affinity (36)).
This property therefore allows us to estimate the fraction of Trp-containing
peptides bound to Q8•MV (and thus the binding affinity) by comparing the
fluorescence intensities of each peptide in the presence and absence of Q8•MV
(Figure 3). Here we use this approach in the design of an assay to rapidly screen
for the relative binding affinity of the library of 104 peptides to the Q8•MV
complex. Therefore, this approach is amenable to parallel screening of peptide
binding using a fluorescence plate reader.
Figure 4 shows the relative fluorescence quenching (45) of the 35 tripeptides
(Figure 4a) at 13 M and the 69 pentapeptides at 30 M (Figure 4b) in the
presence of 50 M Q8•MV complex (Figure 4b). In the tripeptide series, the
extent of fluorescence quenching was in the range 40%-49%, with an average of
45% and a standard deviation of 2%. In the pentapeptide series, the extent of
fluorescence quenching was in the range 26%-47%, with an average of 35% and a
standard deviation of 3%. In each series, the quenching values are remarkably
consistent overall, which indicates that the sequence context of the Trp-binding
site has little influence on the binding affinity. This is particularly true for the
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tripeptide series, with Trp at the N-terminal position. In the pentapeptide series,
the range is larger due to the outliers Lys-Ala-Trp-Ala-Ala (1) with 28 %
quenching, Ala-Lys-Trp-Ala-Ala (2) with 47 % quenching, and Leu-Ala-Trp-AlaAla with 26 % quenching. In order to quantify the range of binding affinities
represented by the outlier peptides, we measured the equilibrium association
constant (Ka) values for the sequence isomers 1 and 2 in complex with Q8•MV.
2.3. Equilibrium Binding Titrations
Figure 5 shows fluorescence titrations of Q8•MV against a constant
concentration of peptide for peptides 1 and 2. The Ka values were 6.2 (±0.3) x 103
M-1 for peptide 1 and 1.7 (±0.1) x 104 M-1 for peptide 2. The small relative binding
affinity between these two peptides (2.7-fold, 0.6 kcal mol-1) is measurable but
insignificant, and therefore these results further underscore the minimal effect of
sequence context on binding to Trp-containing peptides. Using these values in
addition to the affinity of Q8 for MV (9 x 105 M-1) (36) we calculate the difference
in the fraction of peptides 1 and 2 bound to Q8•MV to be 17%, which is very
similar to the observed difference in fluorescence quenching of 19%, as expected.
These results also demonstrate that the assay is sufficiently sensitive to report
small differences in binding energies as relatively large differences in the extent
of fluorescence quenching.

2.4. Conclusions
This study explores the effects of sequence context on the binding of Q8•MV
to Trp-containing peptides. We observe that the identity of the amino acid
residues at positions adjacent to the Trp-binding site, for both N-terminal and
non-terminal Trp, have little if any influence on the strength of interaction. This
result is remarkable given the range of functional groups present in proximity to
the Q8 portal, including sidechains with ammonium, carboxylate, and
hydrophobic groups, all of which would be expected to influence the binding
5

affinity via electrostatic, hydrophobic and/or steric interactions. Therefore,
Q8•MV should be able to bind Trp residues in a broad range of peptide
sequence contexts with predictable binding affinities. This property may prove
useful for targeting Trp residues commonly found at hotspots in protein-protein
interactions (15) and for quantifying surface-exposed tryptophan residues. This
study also demonstrates a powerful approach to the parallel screening of peptide
interactions using a synthetic receptor using the convenient measurement of
fluorescence intensities to estimate relative binding affinities. This approach
would be compatible with a strategy for altering the binding properties of the
receptor, Q8•MV, by tailoring the structure of the viologen cofactor. We are
currently exploring this direction and will report those results in due course.
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3. Materials and Methods
3.1. Instrumentation
UV-visible spectra were acquired at 25 °C using an Agilent 8453
spectrophotometer. Electrospray ionization mass spectrometry (ESI-MS) was
performed on a Thermo LCQ DECA XP mass spectrometer with an electrospray
ion source in the positive ion mode. Fluorescence quenching and titration
experiments were carried out using a Tecan Infinite M200 Pro plate reader, with
280 nm excitation and 350 nm emission wavelengths, 5 nm excitation bandwidth,
20 nm emission bandwidth, and 20 s integration time. The fluorescence spectra
of Trp-Ala-Ala and Q8•MV•Trp-Ala-Ala were collected on a PTI QM-4
spectrophotometer with 280 nm excitation wavelength, 3 nm excitation slit
width, and 5 nm emission slit width.

3.2. Materials
The following compounds were of analytical purity grade and used without
purification: (L)-Fmoc-Ala-OH, (L)-Fmoc-Arg-(Pbf)-OH, (L)-Fmoc-Asn(Trt)-OH,
(L)-Fmoc-Asp(OtBu)-OH, (L)-Fmoc-Cys(Trt)-OH, (L)-Fmoc-Glu(OtBu)-OH, (L)Fmoc-Gln(Trt)-OH, (L)-Fmoc-Gly-OH, (L)-Fmoc-His(Trt)-OH, (L)-Fmoc-Ile-OH,
(L)-Fmoc-Leu-OH, (L)-Fmoc-Lys(Boc)-OH, (L)-Fmoc-Met-OH, (L)-Fmoc-Phe-OH,
(L)-Fmoc-Pro-OH, (L)-Fmoc-Ser(tBu)-OH, (L)-Fmoc-Thr(tBu)-OH, (L)-FmocTrp(Boc)-OH, (L)-Fmoc-Tyr(tBu)-OH, (L)-Fmoc-Val-OH, and O-(benzotriazol-1yl)-N,N,N’,N’-tetramethyluronium hexafluorophosphate (HBTU) (Peptides
International); biotech-grade dimethyl formamide (DMF), diisopropylethylamine
(DIEA), triisopropylsilane (TIS), trifluoroacetic acid (TFA), piperidine, anhydrous
dichloromethane (DCM), and HPLC-grade acetonitrile (Sigma-Aldrich); and
monobasic and dibasic sodium phosphate (VWR). Cucurbit[8]uril (Q8) was
synthesized according to a published procedure (46). Water was obtained from a
Barnstead Nanopure Infinity water system (18 MΩ cm).
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A stock solution of 1.0 M sodium phosphate buffer was adjusted to pH 7.0
and sterile filtered. 10 mM sodium phosphate buffer was made as needed by
diluting the 1.0 M stock and adjusting to pH 7.0. The concentration of methyl
viologen was determined by UV spectroscopy (ε257 = 20,400 M-1cm-1). The
concentration of Q8 was standardized by calorimetric titration with methyl
viologen.

3.3. Peptide Synthesis
Parallel fmoc solid-phase synthesis was carried out using SynPhase Rink amide
Lantern resins from Mimotopes on 8 μmol scale. The resins were mounted to
pins in an 8 x 12 array (i.e., the “rack of resins”) to match the spacing of a
standard 96-well plate. Fmoc deprotection was accomplished by adding 500 μL
of 20% piperidine (v/v) in dimethylformamide (DMF) into each well of a 96 well
deep-well block (Hamilton Research), and then seating the rack of resins into the
wells of the block and allowing the reaction to shake at 120 RPM for 1 hour 25 °C
in an orbital shaker (e.g., a shaking bio-incubator). The rack of resins was then
rinsed thoroughly according to the following procedure: 1) two baths of DMF
and dichloromethane (DCM) were set up; 2) the rack of resins was rinsed
thoroughly and sequentially by dipping first into the two DMF baths, and then
into the two DCM baths, with gentle flicking of the rack between each rinse to
remove excess solution; and 3) the rack of resins was removed and allowed to air
dry for approximately 20 minutes.
To prepare benzotriazoyl-activated amino acid solutions for coupling, we
used 12 equivalents (96 μmol) of fmoc amino acid, 12 equivalents (96 μmol) of diisopropyl ethylamine (DIEA), and 10 equivalents (80 μmol) of HBTU (based on a
limiting quantity of 8 mol resin) dissolved in 0.5 mL of DMF. Amino acid
solutions were scaled to the number of couplings needed per amino acid in the
entire library so that only one stock solution of each amino acid needed to be
8

prepared. The coupling reaction was accomplished by adding 0.5 mL of the
activated amino acid solution into a well of a clean 96-well deep-well block and
then seating the resin rack into the block. The reaction shook (120 RPM) for 3
hours at 25 ºC, and the resins were then rinsed as described above.
Cycles of deprotection and coupling continued in this manner until the
desired sequence was obtained. After the final fmoc deprotection, the resins were
rinsed as described above. Cleavage of the peptides from the resins was carried
out by adding 600 μL of cleavage solution (95% TFA, 2.5% H20, 2.5% TIS), into
each well of a clean 96-well deep-well block, seating the resin rack into it, and
letting the reactions shake at 120 RPM for 1 hour at 25 ºC. The resin rack was
removed, and the cleavage mixture was evaporated overnight with steady
airflow over the plate. After the TFA was removed completely, 800 μL of
nanopure water was added to each well, and the block was heated at 60 ºC for 30
min to dissolve the peptides. The peptide solutions were transferred to 1.5 mL
Eppendorf tubes and lyophilized to dryness. The dry peptides were
resuspended in 1.0 mL of 10 mM phosphate buffer, heated for 15 minutes at 60
ºC, and sonicated if necessary to solubilize the peptides. A random subset of six
peptides was tested for purity, quantity, and identity (See Supporting
Information). The average purity, as determined by analytical HPLC, was 78%.
The average concentration, as determined by UV-spectroscopy (280 = 5500 M-1
cm-1) was 2.1 mM for the tripeptides and 4.8 mM for the pentapeptides, and thus
the peptide recoveries from synthesis were 26% for the tripeptides and 60% for
the pentapeptides. The identities of the peptides were confirmed by ESI-MS. The
peptide solutions were stored at 4 C.

3.4. Fluorescence Quenching Experiments
Q8•MV solutions were prepared by dissolving MV in 10 mM sodium phosphate
buffer, pH 7.0, and determining the concentration of the solution by UV
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spectroscopy (ε257 = 20,400 M-1cm-1). This solution was adjusted to 100 μM in the
same buffer and added to an equimolar quantity of dry Q8. The Q8•MV mixture
was solubilized by mixing and brief ultrasonication followed by heating at 60 °C
for 15-20 minutes. The resulting colorless solution was cooled to room
temperature and sterile-filtered (0.4 m, Teflon).
Fluorescence experiments were carried out in Corning 96-well, black, flatbottomed plates. Peptides sample solutions were prepared by mixing 50 μL of
peptide stock solution with 50 μL of 10 mM phosphate buffer. Peptide + Q8•MV
solutions were prepared by mixing 50 μL of peptide stock solution with 50 μL of
100 μM Q8•MV solution. The peptide stock solutions were 26 μM for tripeptides
and 60 μM for pentapeptides. Therefore, the final concentrations were 13 μM
tripeptide or 30 μM pentapeptide, and 50 μM Q8•MV for samples that contain
Q8•MV. The solutions were mixed by pipetting before reading the fluorescence
intensity on a fluorescence plate reader. The extent of fluorescence quenching
(%Quenched) was determined as the fraction of fluorescent emission intensity (F)
lost upon treatment with Q8•MV:

%Quenched =

(Fpeptide - Fpeptide+Q8•MV )
Fpeptide

Eq. 1

3.5. Fluorescence Titrations
Fluorescence titrations were carried out on peptides 1 and 2. The peptides were
quantified UV spectroscopy (280 = 5500 M-1 cm-1). In the final samples for
measurement, the concentration of peptide was held constant at 0.121 mM for
peptide 1 and 0.206 mM for peptide 2, while the concentration of Q8•MV was
varied over the range 0-1.4 mM. Fluorescence intensity values were obtained
using the plate reader and plotted versus the total peptide concentration. Each
plot was fit to a simple binary equilibrium model using a nonlinear regression to
obtain equilibrium association constant values.
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Figure Captions
Figure 1. (top) Equilibria involved in the formation of the Q8•MV•Trp complex.
(bottom) Chemical formulas of the constituents.
Figure 2. Library of (left) tripeptides and (right) pentapeptides used in this
study. The variable (Var) positions were varied to 18 amino acids (the canonical
20 minus Trp and Cys).
Figure 3. Fluorescence spectral overlay of Trp-Ala-Ala in the absence and
presence of Q8•MV. All species were at 50 M in a buffer of 10 M sodium
phosphate, pH 7.0.
Figure 4. Extent of fluorescence quenching of samples containing (a) 13 M
tripeptide or (b) 30 M pentapeptide in the presence of 50 M Q8•MV at 25 C in
10 mM sodium phosphate, pH 7.0. The identity of the variable position is
indicated along the Y-axis, and the location of the variable positions within the
peptides are indicated by the legends. Average values of at least three
experiments are plotted. Error bars indicate the standard deviation.
Figure 5. Titration of Q8•MV against a constant concentration of peptides 1
(0.121 mM) and 2 (0.206 mM). Relative fluorescence emission intensity values are
plotted. The line indicates the best fit to binary equilibrium binding model.
Equilibrium association constant values, derived from the fits, are shown.
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